FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092247087> ?p ?o ?g. }

• W3092247087 endingPage "106192" @default.
• W3092247087 startingPage "106192" @default.
• W3092247087 abstract "Knowing the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bind to the angiotensin-converting enzyme 2 (ACE2) receptor and to enter cells via endocytosis paved the way for repositioning of old drugs as potential treatment of COVID-19, the disease caused by SARS-CoV-2 infection. This paper highlights the potential of azithromycin and ambroxol to treat COVID-19. Azithromycin and ambroxol share lysosomotropic characteristics, i.e. they penetrate and accumulate inside the late endosomes and lysosomes and may possibly interfere with multiplication of the virus inside cells. In addition, both of these drugs have anti-inflammatory effects. Ambroxol has a proven antiviral effect and a unique stimulatory action on the secretion of surfactant by alveolar type II cells, the main target of SARS-CoV-2. Surfactant may form a fundamental defence mechanism against the virus. Involvement of nasal epithelial cells in SARS-CoV-2 entry suggested advantageous use of inhaled drug delivery of these two drugs over the use of systemic administration. Inhaled drug delivery could aid in targeting the drug to the exact site of action with little or no side effects. To conclude, administration of these two drugs using a special drug delivery system provides two kinds of drug targeting: (i) tissue targeting through using an inhaled drug delivery system to achieve high drug concentrations at the respiratory epithelial tissue that overexpress the ACE2 receptor for virus binding; and (ii) cellular targeting of the virus in the acidic vesicles (late endosomes and lysosomes), which represent the fate of endocytic viruses." @default.
• W3092247087 created "2020-10-15" @default.
• W3092247087 creator A5089079125 @default.
• W3092247087 date "2020-12-01" @default.
• W3092247087 modified "2023-10-01" @default.
• W3092247087 title "Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2" @default.
• W3092247087 cites W1870265643 @default.
• W3092247087 cites W1965932667 @default.
• W3092247087 cites W2000678720 @default.
• W3092247087 cites W2046183696 @default.
• W3092247087 cites W205820741 @default.
• W3092247087 cites W2064360173 @default.
• W3092247087 cites W2077367365 @default.
• W3092247087 cites W2091671824 @default.
• W3092247087 cites W2092078694 @default.
• W3092247087 cites W2131582481 @default.
• W3092247087 cites W2147321811 @default.
• W3092247087 cites W2167384912 @default.
• W3092247087 cites W2168212241 @default.
• W3092247087 cites W2170466149 @default.
• W3092247087 cites W2214238714 @default.
• W3092247087 cites W2558713280 @default.
• W3092247087 cites W2880443987 @default.
• W3092247087 cites W2890393959 @default.
• W3092247087 cites W2893432007 @default.
• W3092247087 cites W2900347296 @default.
• W3092247087 cites W2994840508 @default.
• W3092247087 cites W3001897055 @default.
• W3092247087 cites W3004280078 @default.
• W3092247087 cites W3005212621 @default.
• W3092247087 cites W3008658537 @default.
• W3092247087 cites W3009281473 @default.
• W3092247087 cites W3010673910 @default.
• W3092247087 cites W3010930696 @default.
• W3092247087 cites W3011537081 @default.
• W3092247087 cites W3012883269 @default.
• W3092247087 cites W3013093478 @default.
• W3092247087 cites W3015620943 @default.
• W3092247087 cites W3019458316 @default.
• W3092247087 cites W66711298 @default.
• W3092247087 doi "https://doi.org/10.1016/j.ijantimicag.2020.106192" @default.
• W3092247087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7546948" @default.
• W3092247087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33045350" @default.
• W3092247087 hasPublicationYear "2020" @default.
• W3092247087 type Work @default.
• W3092247087 sameAs 3092247087 @default.
• W3092247087 citedByCount "17" @default.
• W3092247087 countsByYear W30922470872021 @default.
• W3092247087 countsByYear W30922470872022 @default.
• W3092247087 countsByYear W30922470872023 @default.
• W3092247087 crossrefType "journal-article" @default.
• W3092247087 hasAuthorship W3092247087A5089079125 @default.
• W3092247087 hasBestOaLocation W30922470871 @default.
• W3092247087 hasConcept C102747710 @default.
• W3092247087 hasConcept C126322002 @default.
• W3092247087 hasConcept C126511603 @default.
• W3092247087 hasConcept C159047783 @default.
• W3092247087 hasConcept C170493617 @default.
• W3092247087 hasConcept C178790620 @default.
• W3092247087 hasConcept C185592680 @default.
• W3092247087 hasConcept C203014093 @default.
• W3092247087 hasConcept C2522874641 @default.
• W3092247087 hasConcept C2776330663 @default.
• W3092247087 hasConcept C2778907293 @default.
• W3092247087 hasConcept C2779820397 @default.
• W3092247087 hasConcept C2780035454 @default.
• W3092247087 hasConcept C28005876 @default.
• W3092247087 hasConcept C42219234 @default.
• W3092247087 hasConcept C501593827 @default.
• W3092247087 hasConcept C71924100 @default.
• W3092247087 hasConcept C86803240 @default.
• W3092247087 hasConcept C89423630 @default.
• W3092247087 hasConcept C98274493 @default.
• W3092247087 hasConceptScore W3092247087C102747710 @default.
• W3092247087 hasConceptScore W3092247087C126322002 @default.
• W3092247087 hasConceptScore W3092247087C126511603 @default.
• W3092247087 hasConceptScore W3092247087C159047783 @default.
• W3092247087 hasConceptScore W3092247087C170493617 @default.
• W3092247087 hasConceptScore W3092247087C178790620 @default.
• W3092247087 hasConceptScore W3092247087C185592680 @default.
• W3092247087 hasConceptScore W3092247087C203014093 @default.
• W3092247087 hasConceptScore W3092247087C2522874641 @default.
• W3092247087 hasConceptScore W3092247087C2776330663 @default.
• W3092247087 hasConceptScore W3092247087C2778907293 @default.
• W3092247087 hasConceptScore W3092247087C2779820397 @default.
• W3092247087 hasConceptScore W3092247087C2780035454 @default.
• W3092247087 hasConceptScore W3092247087C28005876 @default.
• W3092247087 hasConceptScore W3092247087C42219234 @default.
• W3092247087 hasConceptScore W3092247087C501593827 @default.
• W3092247087 hasConceptScore W3092247087C71924100 @default.
• W3092247087 hasConceptScore W3092247087C86803240 @default.
• W3092247087 hasConceptScore W3092247087C89423630 @default.
• W3092247087 hasConceptScore W3092247087C98274493 @default.
• W3092247087 hasIssue "6" @default.
• W3092247087 hasLocation W30922470871 @default.
• W3092247087 hasLocation W30922470872 @default.
• W3092247087 hasLocation W30922470873 @default.
• W3092247087 hasOpenAccess W3092247087 @default.

• next